Examination of utility of minodronic acid hydrate to osteoporosis by ovarian insufficiency after gynecologic disease treatment
Not Applicable
- Conditions
- Osteoporosis after gynecologic disease treatment
- Registration Number
- JPRN-UMIN000008353
- Lead Sponsor
- Gifu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Cases with a history of serious drug sensitivity or allergy 2)Cases with diseases that are likely to delay esophageal transit such as esophagus stenosis or achalasia 3)Cases that cannot keep upright or sitting positioning for 30 minutes or more when taking it 4)Cases that be judged inadequate for for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The changes of bone mineral density and biochemical markers of turnover after two years from administering beginning
- Secondary Outcome Measures
Name Time Method